Tong Wu

Statistics

Publications

Citations

954

H-Index

Active since

2008

Affiliations

Beijing Tongren Hospital(Current)

Tongji University

Shanghai Pulmonary Hospital

Jiangnan University

State Key Laboratory of Food Science and Technology

Tong Wu is an author at Beijing Tongren Hospital specializing in hematology, acute lymphoblastic leukemia therapy, and chimeric antigen receptor t-cell therapy.

ORCID

Publications per year

2008–2024

Publications

CD22 CAR T-cell therapy in refractory or relapsed B acute lymphoblastic leukemia

Jing Pan, Qing Niu, Biping Deng et al. · Leukemia · 2019 · 251 citations · Full text

Medicine, Hematology, Oncology +17

High efficacy and safety of low-dose CD19-directed CAR-T cell therapy in 51 refractory or relapsed B acute lymphoblastic leukemia patients

Jing Pan, Jieyu Yang, Biping Deng et al. · Leukemia · 2017 · 235 citations

Medicine, Hematology, Oncology +14

Corticosteroids do not influence the efficacy and kinetics of CAR-T cells for B-cell acute lymphoblastic leukemia

Shuangyou Liu, Biping Deng, Zhichao Yin et al. · Blood Cancer Journal · 2020 · 159 citations · Full text

Life Sciences, Immunology, Oncology +12

Combination of <scp>CD19</scp> and <scp>CD22 CAR‐T</scp> cell therapy in relapsed B‐cell acute lymphoblastic leukemia after allogeneic transplantation

Shuangyou Liu, Biping Deng, Zhichao Yin et al. · American Journal of Hematology · 2021 · 124 citations · Full text

Life Sciences, Immunology, Oncology +16

Chimeric antigen receptor T‐cell therapy as a bridge to haematopoietic stem cell transplantation for refractory/relapsed B‐cell acute lymphoblastic leukemia

Yan Zhang, Hui‐Ren Chen, Yanzhi Song et al. · British Journal of Haematology · 2019 · 49 citations

Medicine, Hematology, Oncology +14

1–5 of 11